04/18/2014, Longthera Pharmaceuticals, a pre-clinical stage biopharmaceutical company, based in Jiangsu Province, China, and HQL Pharmaceuticals, a drug discovery company utilizing its super power ChemSpace Scanner (CSS™) computational technology, based in Rehovot, Israel, announced that they have entered into a collaboration agreement for the development of anti cancer small-molecule drug candidate targeting the BCL-2 apoptotic pathway.
Shanghai Association for Science and Technology (SAST) awarded 10 companies, including Shanghai Medicilon Inc., to establish a Shanghai Academicians and Experts Workstation.
Recently, Medicilon passed the CFDA audit on the cancer pharmacology studies which were assigned by one of our customers.
On Jan 29, Medicilon was mentioned by an article which was published on Nature.com - a prominent interdisciplinary scientific journal, with the topics, “Structural biology: More than a crystallographer.”
On Jan 7, 2013, Dr. Chen Chunlin, CEO, will attended the 31st Annual J.P. Morgan Healthcare Conference in San Francisco, USA.